ROBOTIC-ASSISTED SURGERY SYSTEMS MARKET ANALYSIS

Regional Analysis

Global Robotic-assisted Surgery Systems Market: Regional Insights

Based on geography, the global robotic-assisted surgery systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the rise in the burden of chronic diseases, increasing number of surgeries, increasing adoption of surgical robots, and rise in healthcare expenditure in the region. For instance, in March 2021, Asensus Surgical received clearance from the U.S. Food & Drug Administration (FDA) for its Senhance Surgical System, a digital laparoscopic platform that uses augmented intelligence to provide unmatched performance and patient outcomes through machine learning and provides surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization.

Europe and Asia Pacific are also expected to witness robust growth in the global robotic-assisted surgery systems market owing to the increasing prevalence of chronic diseases, rising number of surgical procedures, and rise in adoption of surgical robots in these regions. For instance, robotic-assisted surgery systems, surgical robots, are used in chronic disorders such as minimally invasive cardio procedures with less blood loss and few post-surgery complications. According to European Chronic Disease Alliance (ECDA), chronic diseases are by far the leading cause of mortality in Europe, representing 77% of the total disease burden and 86% of all deaths.

• North America: U.S. and Canada
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa